Medication info
Telmisartan and Amlodipine Tablets 80/5 mg

Telmisartan and Amlodipine Tablets 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Austin Pharmaceuticals Co., Ltd.
Appearance
Biconvex oval double tablet in white and light blue color
Packaging
30 tablets/box [10 tablets/TPP × 3]
Approval status
Active

MFDS item code 202000462 · Approved 2020.01.29 · Insurance code 654305320

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring careful administration’.) In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
Administration of this medicine is not recommended in pediatric patients aged 18 years and younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Austin Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

Used for the treatment of essential hypertension when blood pressure is not adequately controlled with telmisartan or amlodipine monotherapy.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring careful administration’.) In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

Administration of this medicine is not recommended in pediatric patients aged 18 years and younger because its safety and efficacy have not been established.

Precautions

This medication may cause serious damage to the fetus during pregnancy, especially in the second and third trimesters, so pregnant women or those who may become pregnant should not take it. Do not administer this medication to patients with certain diseases, such as severe liver impairment, severe hypotension, cardiogenic shock, or unstable heart failure following acute myocardial infarction. Patients with primary aldosteronism, valvular heart diseases, liver impairment, gastrointestinal disorders, renal artery hypertension, patients on dialysis, and the elderly should use this medication with caution and may need dose adjustment or monitoring of their condition. This medication can commonly cause side effects such as dizziness and peripheral edema, and serious side effects such as syncope have also been reported in rare cases. Therefore, if unusual symptoms occur, immediate consultation with healthcare professionals is required. The administration of this medication should be avoided during pregnancy, and when pregnancy is confirmed, it should be discontinued as soon as possible and changed to another safe treatment. It is also advisable for breastfeeding women not to take this medication. Since this medication lowers blood pressure, hypotension may occur upon initial administration; in such cases, patients should be laid down and infused with fluids if necessary. Patients taking this medication may have increased potassium levels in their blood, so those at risk of hyperkalemia should have their potassium levels regularly checked through blood tests. Patients with impaired renal function should periodically monitor their renal function and electrolyte status before and during treatment with this medication. This medication can interact with other drugs, so patients should inform healthcare professionals of any medications they are currently taking, especially when used concurrently with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, etc. This medication may cause drowsiness or dizziness, so caution should be taken when driving or operating hazardous machinery. In case of overdose, severe hypotension, tachycardia, dizziness, and acute renal failure may occur, requiring immediate emergency treatment, and in severe cases, intensive monitoring of blood pressure and cardiac function is required. This medication is not recommended for children as its safety and efficacy have not been adequately established, and older adults should adjust the dose, increasing it slowly as needed. Finally, this medication should be stored out of reach of children, and it is important to maintain its sealed state until just before use.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • abnormal sensation
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscular hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • diaphoresis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • phototoxic reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • dysuria
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • elevated serum creatinine
  • weight gain
  • weight loss
  • increased serum uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is recommended to store the medication at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Biconvex oval double tablet in white and light blue color

Package unit

30 tablets/box [10 tablets/TPP × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.